IN2010CH03577A - - Google Patents
Download PDFInfo
- Publication number
- IN2010CH03577A IN2010CH03577A IN3577CH2010A IN2010CH03577A IN 2010CH03577 A IN2010CH03577 A IN 2010CH03577A IN 3577CH2010 A IN3577CH2010 A IN 3577CH2010A IN 2010CH03577 A IN2010CH03577 A IN 2010CH03577A
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/989,602 US8703788B2 (en) | 2010-11-26 | 2011-11-11 | Polymorph of nilotinib hydrochloride |
| EP11843202.0A EP2648519A4 (en) | 2010-11-26 | 2011-11-11 | NEW POLYMORPH OF NILOTINIB HYDROCHLORIDE |
| IN3577CH2010 IN2010CH03577A (es) | 2010-11-26 | 2011-11-11 | |
| PCT/IN2011/000779 WO2012070062A2 (en) | 2010-11-26 | 2011-11-11 | Novel polymorph of nilotinib hydrochloride |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3577CH2010 IN2010CH03577A (es) | 2010-11-26 | 2011-11-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2010CH03577A true IN2010CH03577A (es) | 2012-07-20 |
Family
ID=46146222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3577CH2010 IN2010CH03577A (es) | 2010-11-26 | 2011-11-11 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8703788B2 (es) |
| EP (1) | EP2648519A4 (es) |
| IN (1) | IN2010CH03577A (es) |
| WO (1) | WO2012070062A2 (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9376419B2 (en) | 2012-10-15 | 2016-06-28 | Apotex Inc. | Solid forms of nilotinib hydrochloride |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2010CH03577A (es) * | 2010-11-26 | 2012-07-20 | Hetero Research Foundation | |
| WO2014174456A2 (en) * | 2013-04-24 | 2014-10-30 | Dr. Reddys Laboratories Limited | Polymorphic forms of nilotinib hydrochloride |
| WO2015092624A1 (en) | 2013-12-16 | 2015-06-25 | Ranbaxy Laboratories Limited | Nilotinib mono-oxalate and its crystalline form |
| WO2016020891A1 (en) | 2014-08-08 | 2016-02-11 | Dr. Reddy’S Laboratories Limited | Process for the preparation of polymorphic forms of nilotinib |
| PT3189045T (pt) * | 2014-08-11 | 2022-03-17 | Sun Pharmaceutical Ind Ltd | Novos sais de nilotinib e polimorfos do mesmo |
| US10016423B2 (en) | 2014-10-16 | 2018-07-10 | Apotex Inc. | Solid forms of nilotinib hydrochloride |
| EP3404025B1 (en) | 2017-05-16 | 2019-12-04 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of pure nilotinib and its salt |
| CN107188887A (zh) * | 2017-06-15 | 2017-09-22 | 苏州立新制药有限公司 | 一种尼洛替尼氧化降解杂质及其制备方法 |
| CZ2017821A3 (cs) | 2017-12-20 | 2019-07-03 | Zentiva, K.S. | Léková forma obsahující krystalický nilotinib |
| JP7409696B2 (ja) | 2018-06-15 | 2024-01-09 | ハンダ ファーマシューティカルズ インコーポレイテッド | キナーゼ阻害剤の塩およびその組成物 |
| US20210380557A1 (en) * | 2018-11-05 | 2021-12-09 | Laurus Labs Limited | Crystalline form of nilotinib hydrochloride, process for its preparation and pharmaceutical composition containing the same |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4216318A (en) * | 1975-12-29 | 1980-08-05 | Smith Kline & French Laboratories Limited | Heterocyclic alkyl 4-pyrimidones |
| JP2657760B2 (ja) * | 1992-07-15 | 1997-09-24 | 小野薬品工業株式会社 | ４−アミノキナゾリン誘導体およびそれを含有する医薬品 |
| US7196095B2 (en) * | 2001-06-25 | 2007-03-27 | Merck & Co., Inc. | (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds |
| GB0215676D0 (en) * | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
| GB2398565A (en) * | 2003-02-18 | 2004-08-25 | Cipla Ltd | Imatinib preparation and salts |
| GT200600316A (es) * | 2005-07-20 | 2007-04-02 | Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida. | |
| GT200600315A (es) * | 2005-07-20 | 2007-03-19 | Formas cristalinas de 4-metilo-n-[3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo]-3-(4-pyridina-3-ilo-pirimidina-2-iloamino)-benzamida | |
| WO2010009402A2 (en) * | 2008-07-17 | 2010-01-21 | Teva Pharmaceutical Industries Ltd. | Nilotinib intermediates and preparation thereof |
| ES2394258T3 (es) | 2008-11-05 | 2013-01-30 | Teva Pharmaceutical Industries Ltd. | Formas cristalinas de Nilotinib HCL |
| IN2010KO00035A (es) * | 2010-01-15 | 2016-09-02 | ||
| PL2571863T3 (pl) * | 2010-06-21 | 2016-03-31 | Teva Pharma | Sole nilotynibu i ich postacie krystaliczne |
| CN102453024B (zh) * | 2010-10-27 | 2014-09-03 | 浙江九洲药业股份有限公司 | 一种尼罗替尼盐酸盐晶型及其制备方法 |
| IN2010CH03577A (es) * | 2010-11-26 | 2012-07-20 | Hetero Research Foundation |
-
2011
- 2011-11-11 IN IN3577CH2010 patent/IN2010CH03577A/en unknown
- 2011-11-11 EP EP11843202.0A patent/EP2648519A4/en not_active Withdrawn
- 2011-11-11 WO PCT/IN2011/000779 patent/WO2012070062A2/en active Application Filing
- 2011-11-11 US US13/989,602 patent/US8703788B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9376419B2 (en) | 2012-10-15 | 2016-06-28 | Apotex Inc. | Solid forms of nilotinib hydrochloride |
Also Published As
| Publication number | Publication date |
|---|---|
| US8703788B2 (en) | 2014-04-22 |
| EP2648519A4 (en) | 2014-04-30 |
| US20130245052A1 (en) | 2013-09-19 |
| WO2012070062A2 (en) | 2012-05-31 |
| EP2648519A2 (en) | 2013-10-16 |
| WO2012070062A3 (en) | 2012-06-21 |